Plain-English translation of NCT05534750 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial compares three different antibiotic treatments for tuberculosis to see which one works best at killing the bacteria early on. You would take either tedizolid (the new medication being tested), linezolid (an existing antibiotic), or a combination of four standard tuberculosis drugs for just 7 days. The researchers will measure how quickly each treatment reduces the bacteria in your sputum samples to understand which approach is most effective.
Tuberculosis, especially drug-resistant forms, is a serious infection that requires long treatments with multiple medications. Researchers want to find out whether this medication could be more effective or easier to use than current options, potentially improving how patients are treated.
You likely qualify if…
You likely don't qualify if…
You would come to the clinic and be randomly assigned to one of three treatment groups. For 7 days, you would take one of the three antibiotic regimens each morning as directed. During these 7 days, you would provide a sputum sample (phlegm coughed up from your lungs) each day so researchers can measure how quickly the bacteria are being killed. After treatment ends, you would return for a final visit around day 30 for blood tests and a check-up to make sure you are doing well.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
France